Steris (STE) EBT Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 329.00 |
| Dec 31, 2025 | 181.00 |
| Sep 30, 2025 | 273.00 |
| Jun 30, 2025 | 279.00 |
| Mar 31, 2025 | 310.00 |
| Dec 31, 2024 | 160.00 |
| Sep 30, 2024 | 718.00 |
| Jun 30, 2024 | 1,669.00 |
| Mar 31, 2024 | -211.00 |
| Dec 31, 2023 | -263.00 |
| Sep 30, 2023 | -511.00 |
| Jun 30, 2023 | -214.00 |
| Mar 31, 2023 | -212.00 |
| Dec 31, 2022 | -188.00 |
| Sep 30, 2022 | -132.00 |
| Jun 30, 2022 | -38.00 |
| Mar 31, 2022 | -708.00 |
| Dec 31, 2021 | 679.00 |
| Sep 30, 2021 | -654.00 |
| Jun 30, 2021 | -1,599.00 |
| Mar 31, 2021 | -2,530.00 |